Premas Biotech specializes in difficult-to-express proteins for vaccine, therapeutics, and drug discovery in preclinical and clinical studies, along with production (GMP compliant) for global markets.

We offer integrated services from rapid deep scouting to clinical supply, derived from Premas’ high yielding Bacterial, Yeast and Mammalian platforms. Our quality by design process produces high-quality recombinant proteins for drug and vaccine development programs, which includes scaleup, upstream and downstream processing, process development and manufacturing optimization.

Premas also offers end-to-end solutions in generation of therapeutic monoclonal antibodies for oncology and autoimmune diseases, which includes lead identification and characterization, generation of Proof-of-Concept from preclinical studies, GMP manufacturing of lead candidates for GLP tox studies and clinical trials, under ICH guidelines.